NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE068V01023.png)
Gland Pharma Share Price
GLAND
₹2,016.60+₹11.65 (0.58%) TodayLast updated on 26 Jul, 2024 | 15:49 IST
₹1,990.00₹2,068.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹2,009.95 | Close₹2,004.95 |
Circuit range₹2,405.90 - ₹1,604.00 | Day range₹1,990.00 - ₹2,068.00 | Year range₹1,190.00 - ₹2,194.00 |
Volume1,27,144 | Avg. traded₹2,031.38 | Revenue (12m)₹5,665 Crs |
Gland PharmaGland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.
Gland Pharma Key indicators
52 week high₹2,194.00 | 52 week low₹1,190.00 | P/E ratio42.26 |
P/B ratio3.78 | ROE10.28% | ROCE13.97% |
Dividend yield1% | Debt/Equity ratio | EPS47.11 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
63%
Hold
12%
Sell
25%
This analysis is based on the reviews of 16 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin34.81% | Net profit margin21.45% |
ROE10.28% | ROA9.34% |
ROCE13.97% |
Learn more
Gland Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹2,014.05 | ₹2,004.95 | -0.73% |
Wed, Jul 24 2024 | ₹1,999.00 | ₹2,019.60 | |
Tue, Jul 23 2024 | ₹2,006.45 | ₹1,981.75 | -0.65% |
Mon, Jul 22 2024 | ₹1,990.25 | ₹1,994.75 | |
Fri, Jul 19 2024 | ₹1,996.00 | ₹1,990.60 | -0.95% |
Thu, Jul 18 2024 | ₹2,066.95 | ₹2,009.75 | -2.01% |
Tue, Jul 16 2024 | ₹2,003.00 | ₹2,051.00 | |
Mon, Jul 15 2024 | ₹2,041.20 | ₹2,001.20 | -1.50% |
Events
Corporate actions
Dividend • ₹20/share
Ex date
Learn more